Defense World
08 Aug 2026, 07:32 UTC · 7w ago
Verdict
Headline takes no side. We score XRAY +0.20 across five claims — slightly bullish.
+0.20slightly bullish
More positive than 57% of ticker scores this week
What the story claims
5 claims · scored −1 bearish … +1 bullish
Dentsply Sirona reported Q2 earnings of $0.52 EPS and $898 million in revenue, beating consensus estimates of $0.35 EPS and $889.93 million.
More positive than 94% of claims this week
Barclays reduced its price target for XRAY from $12.00 to $9.00 with an 'underweight' rating.
So whatA price target cut below the current trading price of $12.12 signals significant downward pressure from a major analyst.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More negative than 84% of claims this week
Institutional investors have significantly increased holdings, including AQR Capital Management adding over 6.9 million shares and Southpoint Capital Advisors initiating a $116 million position.
More positive than 67% of claims this week
Company directors Brian P. Mckeon and Brian T. Gladden purchased a combined total of 19,985 shares in June.
More positive than 54% of claims this week
The company's quarterly revenue decreased by 4.1% on a year-over-year basis.
More negative than 68% of claims this week
Which stocks this story touches
More positive than 57% of ticker scores this week
Positive institutional buying and earnings beat are offset by several analyst downgrades and 'sell' ratings.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−25.9%
Price is moving against the score
$8.98 vs $12.12 close before publication (Aug 7) · not market-adjusted
XRAY chart →
